Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis
Launched by COMBINED MILITARY HOSPITAL ABBOTTABAD · Dec 1, 2022
Trial Information
Current as of January 16, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • both genders with live detected on clinical examination and by combing wet hair with a fine toothed lice detection comb ages 8-36 years weight \>15 kgs
- Exclusion Criteria:
- • pregnancy breast feeding using any pediculicidal medication within the preceding two weeks of treatment hairstyle that may be difficult to comb
Trial Officials
Bushra Muzaffar, FCPS
Principal Investigator
Combined Military Hospital Abbottabad
About Combined Military Hospital Abbottabad
The Combined Military Hospital Abbottabad is a premier healthcare institution dedicated to providing high-quality medical services to military personnel and their families, as well as the local civilian population. As a clinical trial sponsor, the hospital leverages its advanced medical facilities and expertise in various healthcare disciplines to conduct innovative research aimed at improving patient outcomes and advancing medical knowledge. The institution is committed to upholding the highest ethical standards in clinical research, ensuring participant safety and compliance with regulatory guidelines while fostering collaboration with national and international research entities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abbottabad, Kpk, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials